Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells

A. Avan, F. Crea, E. Paolicchi, N. Funel, E. Galvani, V.E. Marquez, R.J. Honeywell, R. Danesi, G.J. Peters, E. Giovannetti

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1735-1746
JournalMolecular Cancer Therapeutics
Volume11
Issue number8
DOIs
Publication statusPublished - 2012

Cite this